A nurse recently administered filgrastim intravenously to a client who has ccer and is receiving cytotoxic chemotherapy. For which of the following data, discovered after the medication was administered, should the nurse file an incident report?
The nurse flushed the client's IV line with dextrose 5% in water before and after the medication was administered.
The client's absolute neutrophil count was 2.500/mm3 before the medication was administered.
The client had chemotherapy 12 hr before the medication was administered.
The medication vial sat at room temperature for 2 hr before it was administered.
The Correct Answer is D
A: Flushing an IV line with dextrose 5% in water before and after medication administration is a common practice to ensure that the medication is delivered properly and to prevent interactions in the IV line. This would not typically require an incident report.
B: An absolute neutrophil count of 2.500/mm3 is within the normal range for patients undergoing chemotherapy and would not typically necessitate an incident report.
C: Having chemotherapy 12 hours before the administration of filgrastim does not contraindicate its use and is within the appropriate time frame as filgrastim is often given after chemotherapy to help recover white blood cell counts.
D: According to the guidelines, filgrastim should be stored in the refrigerator and allowing it to sit at room temperature for 2 hours could compromise its effectiveness. This is a deviation from the medication's storage requirements and could potentially harm the patient, thus an incident report should be filed.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is C
Explanation
Choice A rationale:
Raloxifene is not used to treat urinary tract infections.
Choice B rationale:
Raloxifene is not used to treat deep-vein thrombosis.
Choice C rationale:
Raloxifene is a medication used to treat and prevent osteoporosis in postmenopausal women. It is a selective estrogen receptor modulator (SERM) that helps improve bone density and reduce the risk of fractures.
Choice D rationale:
Raloxifene is not used to treat hypothyroidism.
Correct Answer is B
Explanation
Choice A rationale:
Naloxone is an opioid antagonist and does not increase pain relief.
Choice B rationale:
Naloxone is used to reverse opioid overdose, and an increased respiratory rate is a therapeutic effect, as it helps to counteract the respiratory depression caused by opioids.
Choice C rationale:
Decreased blood pressure is not a therapeutic effect of naloxone.
Choice D rationale:
Naloxone is not used to treat nausea directly.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today